Tebemicina: Full Drug Profile
Tebemicina - General Information
Antibiotic substance produced by Streptomyces garyphalus. [PubChem]
Pharmacology of Tebemicina
Tebemicina, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Tebemicina works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria
Tebemicina for patients
Take this by mouth as directed usually every 12 hours for the first two weeks. This medication works best when the amount of medicine in your body is kept at a constant level. Do this by taking the medication at evenly spaced intervals throughout the day and night. Continue using this for the full time prescribed. It may be necessary to continue therapy for tuberculosis for several months to one year or more. Stopping the medication too early may result in ineffective treatment.
Tebemicina Interactions
May interact with wthionamide (Trecator-SC) and isoniazid (Nydrazid).
Tebemicina Contraindications
Additional information about Tebemicina
- Tebemicina Indication
Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).
- Mechanism Of Action
- Tebemicina is an analog of the amino acid D-alanine. It interferes with an early step in bacterial cell wall synthesis in the cytoplasm by competitive inhibition of two enzymes, L-alanine racemase, which forms D-alanine from L-alanine, and D-alanylalanine synthetase, which incorporates D-alanine into the pentapeptide necessary for peptidoglycan formation and bacterial cell wall synthesis.
- Generic Name
- Cycloserine
- Synonyms
- alpha-Cycloserine; Cicloserina; D-CS; D-Cycloserine; D-Cycloserine synth. BP 88; D-Cycloserine, synthetic; D-Oxamicina; D-Oxamycin; DL-Cycloserine; L-Cycloserine
- Drug Category
- Antibiotics
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Cycloserine
- Closerin; Closina; Cyclomycin; Cyclorin; Cycloserin; Farmiserina; Farmiserine; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamycin; Oxymycin; Seromycin; Tebemicina; Tisomycin; Wasserina;
- Absorption
- Rapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration.
- Toxicity (Overdose)
- Oral LD50 in mouse is 5290 mg/kg, and in rat is over 5000 mg/kg. Symptoms of a cycloserine overdose include drowsiness, confusion, headache, dizziness, irritability, numbness and tingling, difficulty speaking, paralysis, abnormal behavior, seizures, and unconsciousness.
- Half Life
- Half-life in patients with normal renal function is 10 hours, and is prolonged in patients with impaired renal function.
- Dosage Forms of Tebemicina
- Capsule Oral
- Chemical IUPAC Name
- 4-amino-1,2-oxazolidin-3-one
- Chemical Formula
- C3H6N2O2
- Cycloserine on Wikipedia
- https://en.wikipedia.org/wiki/Cycloserine
- Organisms Affected
- Enteric bacteria and other eubacteria
